Grants per year
Fingerprint
Dive into the research topics where Przemyslaw Twardowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
(PQ11) Immune modulatory effects of white button mushroom in prostate cancer - A translational research
Chen, S. S., Lau, C. C. & Twardowski, P.
09/1/19 → 08/31/24
Project: Research
-
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
Lara, P. N., Mayerson, E., Gertz, E., Tangen, C., Goldkorn, A., van Loan, M., Hussain, M., Gupta, S., Zhang, J., Parikh, M., Twardowski, P., Quinn, D. I., LeBlanc, M., Vogelzang, N. J., Thompson, I. & Agarwal, N., Feb 2024, In: European Urology. 85, 2, p. 171-176 6 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
Lara, P. N., Mayerson, E., Gertz, E., Tangen, C., Goldkorn, A., van Loan, M., Hussain, M., Gupta, S., Zhang, J., Parikh, M., Twardowski, P., Quinn, D. I., LeBlanc, M., Thompson, I. & Agarwal, N., 2024, (Accepted/In press) In: Prostate Cancer and Prostatic Diseases.Research output: Contribution to journal › Article › peer-review
-
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men with Suspected Prostate Cancer Recurrence: Results from a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
Jani, A. B., Ravizzini, G. C., Gartrell, B. A., Siegel, B. A., Twardowski, P., Saltzstein, D., Fleming, M. T., Chau, A., Davis, P., Chapin, B. F. & Schuster, D. M., Sep 1 2023, In: The Journal of Urology. 210, 3, p. 411-412 2 p.Research output: Contribution to journal › Comment/debate
3 Scopus citations -
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Jani, A. B., Ravizzini, G. C., Gartrell, B. A., Siegel, B. A., Twardowski, P., Saltzstein, D., Fleming, M. T., Chau, A., Davis, P., Chapin, B. F., Schuster, D. M., Allaf, M., Avery, R. J., Avril, N., Barker, H., Belkoff, L., Bostrom, P., Cher, M. L., Chisholm, D., Covington, M. F., & 29 others , Aug 1 2023, In: The Journal of Urology. 210, 2, p. 299-311 13 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
LIGHTHOUSE Study Group, Oct 2023, In: European Urology. 84, 4, p. 361-370 10 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations